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ABSTRACT
THE ELASMOBRANCH-MICROBE RELATIONSHIP: TRIMETHYLAMINE
N-OXIDE SYNTHESIS, UREA HYDROLYSIS, AND MICROBEOSMOLYTE INTERACTIONS IN THE ATLANTIC
STINGRAY, DASYATIS SABINA
by Kaitlin Kelly Doucette
December 2016
The elasmobranch osmoregulatory strategy is predicated on the
accumulation of nitrogenous compounds, primarily urea and trimethylamine n¬oxide (TMAO). Despite the abundance of these plasma osmolytes, it is notable
that elasmobranchs appear to lack urease and TMA oxidase (Tmase), enzymes
that scavenge urea-nitrogen and synthesize TMAO, respectively. However,
urease and Tmase are found in many species of bacteria. Therefore, I
hypothesized that intestinal bacteria are responsible for urease and Tmase
activity in elasmobranchs. Absent dietary nitrogen sources, I evaluated the
effects of reduced intestinal microbiota on osmoregulation in Atlantic stingray
(Dasyatis sabina) in vivo. D. sabina were given daily broad-spectrum antibiotics
per os and monitored for weight loss, plasma osmolality, amine metabolites,
urea, and TMAO. qRT-PCR was used to determine the efficacy of antibiotics at
reducing the intestinal microbial community and to quantify the hepatic
expression of carbomoyl phosphate synthetase III (CPS III), the rate-limiting
enzyme in urea production. Though antibiotics significantly reduced the bacterial
community in the D. sabina gut, there was no significant change in plasma
ii

osmolality, urea, or TMAO. However, amine metabolites changed significantly
within control and antibiotic groups including benzoic acid, arginine, creatinine
and L-citrulline. Also observed was significant down-regulation of CPS III
expression, suggesting that urea production decreased in antibiotic-treated
individuals. My findings suggest that elasmobranch osmoregulation is robust to
microbiome perturbation and supports the hypothesis that plasma osmolytes are
highly conserved in elasmobranchs. This is the first study to test the efficacy and
subsequent effect of antibiotics on the elasmobranch intestinal microbiome and
osmoregulation.
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CHAPTER I - INTRODUCTION
Osmoregulation is a critical physiological process in the aquatic
environment whereby organisms constantly and intimately interact with water and
dissolved solutes. Compared to our comprehensive understanding of teleost
osmoregulatory strategy, a gap exists in our knowledge regarding several critical
aspects of elasmobranch osmoregulation – primarily the synthesis, maintenance,
and catabolism of several critical nitrogenous osmolytes. Similar to teleosts,
elasmobranchs colonize diverse environments with salinities ranging from
freshwater to hypersaline water (Hamlett 1999; Klimley and Oerdig 2013);
however, elasmobranchs employ a unique osmoregulatory strategy to cope with
the complexities of the aquatic environment. While teleosts and elasmobranchs
both actively excrete Na+ and Cl- (the dominant ions in seawater) via specialized
chloride cells in the gills, through urinary excretion, and – in the case of
elasmobranchs – use of the rectal gland, teleosts maintain hypo-osmotic plasma
with respect to seawater (~360 milliosmoles) whereas elasmobranchs maintain
plasma of equivalent osmolality to that of seawater (~1000 milliosmoles).
Elasmobranchs maintain iso-osmotic – or slightly hyper-osmotic plasma – by
accumulating high levels of nitrogenous compounds such as urea,
trimethylamine n-oxide (TMAO), amino acids, sarcosine, and betaine (Robertson
1975; Pang et al. 1977; Yancey and Somero 1979, 1980; Ballantyne et al. 1987;
Perlman and Goldstein 1988), which counteract the osmotic pressure of the
seawater.
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Of the total dissolved solutes in elasmobranch plasma, the importance of
urea and TMAO to elasmobranch osmoregulation cannot be overstated. Urea
and TMAO comprise roughly 60% of total plasma solutes: 40% and 20%,
respectively (Goldstein and Funkhouser 1972; Ballantyne and Robinson 2010),
which is notably more than any other dissolved solute in elasmobranch plasma.
However, despite the importance of urea and TMAO to elasmobranch
osmoregulation, our understanding of nitrogenous osmolyte synthesis,
scavenging, and metabolism in these taxa is limited.
Urea
The importance of elasmobranch urea synthesis and retention is dictated
by the osmotic demands of the aquatic environment. In marine elasmobranchs,
urea is stored in blood plasma at extraordinarily high concentrations compared to
other aquatic organisms (300-500mM) (Yancey 1994) and, as previously
mentioned, constitutes a major proportion of osmolytes: typically, 40% of total
blood solutes (Ballantyne and Robinson 2010). To a lesser extent, urea is
synthesized and retained in certain freshwater stenohaline species such as the
isolated Dasyatis sabina population in St. Johns River, Florida (Johnson and
Snelson 1996), as well as species of Himantura in southeast Asia (Tam et al.
2003). Other freshwater stenohaline species such as Potamotrygon spp.
however, have lost the ability to synthesize urea via the ornithine-urea cycle (OUC) and no longer retain urea (Anderson 1991). Interestingly, it has been
postulated that the ureosmotic strategy of elasmobranchs has contributed to the
low penetrability of elasmobranchs into freshwater environments (Ballantyne and
2

Robinson 2010). Additionally, urea is energetically costly to produce via the OUC (5 ATP per mole of urea) (Anderson 2001), which means urea must be highly
conserved within tissues. For example, although urea represents 80-97% of
elasmobranch nitrogenous waste (Anderson 2001; Kajimura et al. 2006), the total
amount of excreted nitrogenous waste is significantly reduced by retention
mechanisms in the gills and kidneys (Fines et al. 2001; Morgan et al. 2003;
Kajimura et al. 2006). This indicates that, rather than constantly manufacturing
large quantities of urea to account for large losses via excretion or diffusion, a
majority of urea is retained.
As with many other aspects of physiology, elasmobranchs employ a
unique method of urea synthesis. Urea is primarily synthesized via the O-UC
(Figure 1) in the mitochondria of hepatocytes (Smith 1936; Casey and Anderson
1985; Perlman and Goldstein 1988; Mommsen and Walsh 1991) though recent
studies found evidence that the O-UC also occurs in extrahepatic elasmobranch
tissues such as skeletal muscle and the intestines (Tam et al. 2003; Steele et al.
2005). Briefly, in most vertebrate taxa, ammonia is converted to carbomoyl
phosphate, which then enters the O-UC and – through a series of enzymatic
reactions – is converted to ornithine (which re-enters the cycle) and urea. In this
process in mammals and amphibians, carbomoyl phosphate synthetase I (CPS I)
is the first enzyme in the cycle (Meijer et al. 1990; Campbell 1991). Most teleosts
excrete nitrogen as ammonia thereby negating the necessity of a CPS enzyme
(Anderson 1991). In contrast, the first enzyme in the elasmobranch O-UC is CPS
III (Anderson 1991; Anderson 2001). Unlike CPS I, which uses ammonia as a
3

nitrogen-donating substrate, CPS III uses glutamine to synthesize carbomoyl
phosphate (Perlman and Goldstein 1988; Ballantyne and Robinson 2010).
Because of this, glutamine must first be synthesized from ammonia by glutamine
synthetase (GSase), an accessory enzyme located in mitochondria (Casey and
Anderson 1985). As such, glutamine is the limiting substrate for the O-UC in
elasmobranchs and CPS III is the rate-limiting step in this cycle.
The importance of this enzymatic “check-point” is evident when
considering the method by which urea-nitrogen is scavenged. Urea is hydrolyzed
via urease to ammonia and carbon dioxide. If ammonia was used as a precursor,
the catabolism of urea would directly feed back into the O-UC, thus prompting
further synthesis of urea without additional regulation. Further, if a decrease in
total urea concentration was advantageous, hydrolysis of urea would likely have
little effect on urea concentrations; if ammonia was indeed the precursor to urea
synthesis in elasmobranchs, the end-product of urea break-down would be the
precursor to urea sythesis. Thus, having an intermediary amine – glutamine –
and not ammonia as the substrate for CPS III allows urea to be recycled via
urease hydrolysis.
Urea-nitrogen recycling would be highly benefial given the nitrogen
demands of elasmobranch physiology. Elasmobranchs are considered nitrogenlimited (Wood et al. 2005), thus a method of breaking down urea would allow
elasmobranchs to re-use urea-nitrogen. It is worth noting that glutamine, which is
synthesized from ammonia (the product of urea hydrolysis), can also be utilized
as an oxidative substrate in numerous elasmobranch tissues (Ballantyne 1997).
4

Thus, glutamine produced via urea hydrolysis could be used as an oxidative fuel
in elasmobranch tissue.
A method of recycling urea-nitrogen would also be advantageous given
the varying osmotic demands of the aquatic environment, particularly for
euryhaline species that can rapidly alter plasma osmolytes in response to
environmental conditions. However, it is striking that these taxa appear to lack
any mechanism for urea catabolism. According to the current literature, urease –
the enzyme responsible for urea hydrolysis – has not been identified in
elasmobranchs (Wood 1950; Simidu and Oisi 1951; Knight et al. 1988). Urease
activity has, however, been identified in species of fungi, plants, invertebrates,
and – perhaps most notably – bacteria. The existence of urease-positive
bacterial species is compelling because of microbiological studies of
elasmobranch tissues, which found multiple species of bacteria inhabiting healthy
elasmobranch tissues (Grimes et al. 1985; Grimes et al. 1990; Mylniczenko et al.
2007). For elasmobranch hosts, these endogenous bacteria could confer the
requisite urease activity that elasmobranchs require but do not inherently
possess. Indeed, in vitro treatment of the livers of lemon shark (Negaprion
brevirostris) and tiger shark (Galeocero cuvier) with both antibiotics and 14Clabeled urea yielded reduced urease activity to the point that it was effectively
non-existent (Knight et al. 1988). Knight et al. (1988) further concluded that 65%
of all bacteria taxa isolated from shark tissue using culture-based methods
(Grimes et al. 1985) are urease-positive, meaning that these bacteria are
capable of urea hydrolysis, in addition to those species that are able to utilize
5

urea as a sole energy source (e.g. Vibrio damsela and V. charchariae syn. V.
harveyi) (Grimes et al. 1984).
The high proportion of urease-positive bacteria in elasmobranch tissues –
tissues that contain high concentrations of urea – led to the hypothesis that
bacteria are involved in regulating urea concentrations in elasmobranchs (Knight
et al. 1988), specifically by hydrolyzing excess urea and recycling urea-nitrogen
in the form of ammonia. Even without further evidence for the existence of
bacteria within elasmobranch tissue, the bacterial urease hypothesis could
certainly extend to the bacteria within the elasmobranch gut. Indeed, a study of
urea flux within the intestine of spiny dogfish (Squalus acanthias) found an
inverse relationship between urea and ammonia within the proximal and distal
regions of the gut, which the authors postulated could be due to bacterial urea
hydrolysis (Anderson et al. 2009). There is evidence for this kind of vertebratebacteria relationship in other taxa: studies of ruminants found that bacteria in the
rumen were responsible for much of the urease-driven “nitrogen scavenging”
during periods of low nitrogen inputs, which is a clear advantage over reliance on
regular nitrogen input from the diet (Harmeyer and Martens, 1980). Additionally,
the use of glutamine by CPS III in elasmobranch urea synthesis provides a key
step in the regulation of this process. As mentioned previously, ammonium must
first be converted to glutamine in order to re-enter the elasmobranch O-UC.
Thus, CPS III provides a useful “check-point” for urea synthesis given that
ammonia produced by microbial urease would not directly re-enter the
elasmobranch O-UC.
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If endogenous tissue or gut bacteria in elasmobranchs are involved in the
hydrolysis of urea via urease, such a relationship will represent a novel
vertebrate-microbe relationship. Even in ruminants, arguably the best example of
microbial urea-nitrogen scavenging (UNS) with which to compare
elasmobranchs, this proposed elasmobranch-microbe relationship is
physiologically unique. Rumen bacteria hydrolyze urea-nitrogen to synthesize
amino acids and proteins that the host can then reabsorb (Mobley and Hausinger
1989; Lapierre and Lobley 2001; Stewart and Smith 2005) and thus the
relationship is predicated on an exchange of dietary nutrients. In contrast,
elasmobranchs consume a nitrogen-rich diet that allows them to accumulate high
levels of urea; thus the relationship between elasmobranchs and intestinal
bacteria is predicated on osmoregulation. Both groups rely on this microbial
process for nitrogen scavenging; the difference between ruminants and
elasmobranchs is in how each group utilizes urea and the urea-derived nitrogen
compounds. Arguably, in elasmobranchs, urea is an even more critical
compound due to its accumulation as an abundant, important osmolyte. Because
of the hypothesized importance of bacteria to the osmoregulatory urea cycle in
elasmobranchs, further study is clearly warranted.
Trimethylamine n-oxide
In addition to the complexity of urea cycling, urea is also protein-toxic in
high concentrations (Yancey et al. 1982; Yancey 1994, 2005). Given the
exceptionally high urea concentration found in elasmobranch tissues, without
compensatory mechanisms urea would have deleterious effects on normal
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protein and enzymatic function. To counteract the effects of urea toxicity,
methylamines such as TMAO are accumulated in tissues, which allows normal
protein function and returns enzymatic Km values to pre-urea levels by
strengthening the structure of water molecules surrounding enzymes and
indirectly interacting with enzyme functional groups (Yancey and Somero 1979;
Yancey et al. 1982; Zou et al. 2002; Qu and Bolen 2003). The ratio of urea to
TMAO is relatively constant: normally between 3:1 and 2:1 in all species of
elasmobranchs studied to date (Yancey and Somero 1980; Steele et al. 2005).
Although the presence and importance of TMAO has been well
established in elasmobranchs (Goldstein and Dewitt-Harley 1973; Strom et al.
1979; Yancey and Somero 1979, 1980; Yancey 2001; Seibel and Walsh 2002),
the mechanism by which TMAO is accumulated is still debated. In mammalian
models, TMAO is synthesized from quaternary ammonium salts such as choline
and carnitine, which are broken into trimethylamine (TMA) by bacteria in the gut
(Al-Waiz et al. 1992; Wang et al. 2011; Koeth et al. 2013; Hartiala et al. 2014).
This microbial-mammalian model appears to be consistent with the breakdown of
choline to TMA in elasmobranchs (Bilinski 1960; Goldstein and Funkhouser
1972). TMA is then absorbed from the intestine by colonocytes – cells in the
intestinal epithelium – and transported to the liver (Wang et al. 2011; Russell et
al. 2013; Hartiala et al. 2014). In the liver, TMA is oxidized to TMAO by
trimethylamine oxidase (Tmase) (Beatty 1938; Strom 1980; Seibel and Walsh
2002), an enzyme that specializes in TMA oxidation (Goldstein and DeWittHarley 1973), or an isoform of flavin-containing monooxygenase (FMO), which
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oxidizes a broader range of tertiary amines (Ziegler and Mitchell 1972; Schlenk
1998). FMO isoform 3 (FMO3) is the hepatic isoform that catalyzes the
monoxygenation of TMA in mammalian models (Lang et al. 1998). Traditionally,
studies of FMOs have focused on mammalian models, however, recently FMOs
have been identified in bacteria and several teleosts (Schlenk 1998), most
notably the euryhaline teleost Oncorhynchus mykiss (Larsen and Schlenck
2001). In O. mykiss challenged with an increase in salinity, an increase in FMO
expression was concurrent with TMAO accumulation in muscle tissue (Larsen
and Schlenk 2001).
In elasmobranchs, however, there is conflicting and sporadic evidence as
to the distribution and presence of Tmase or FMO3. Of elasmobranch species
studied to date, only five species have demonstrated putative Tmase activity: S.
acanthius (Schlenk and Li-Schlenk 1994), silky shark (Carcharhinus falciformis)
(Schlenk and Li-Schlenk 1994), grey smooth-hound shark (Mustulus californicus)
(Baker et al. 1963), nurse shark (Ginglymostoma cirratum (Goldstein and
Funkhouser 1972; Goldstein and DeWitt-Harley 1973), and lemon shark
(Negaprion brevirostris) (Goldstein and DeWitt-Harley 1973). Additionally, these
studies used in vitro and in vivo conversion of 14C-TMA-HCl and choline-methyl14C

to 14C-TMAO as a proxy for Tmase or FMO3 activity: essentially, production

of 14C-TMAO indicates a putative Tmase or FMO must exist in elasmobranch
tissue. However, as all aforementioned studies did not employ antibiotics in vivo
or in vitro, it would be impossible to elucidate whether the enzyme activity in
elasmobranchs was of bacterial or elasmobranch origin. Other elasmobranch
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species either have not been studied or were found to have no detectable levels
of Tmase (Goldstein and DeWitt-Harley 1973; Seibel and Walsh 2002).
Due to conflicting evidence for Tmase or FMO in most elasmobranch
species, it was theorized that TMAO may originate entirely from dietary inputs
and is therefore accumulated and conserved (Seibel and Walsh 2002; Treberg
and Dreidzic 2006; Treberg et al. 2006). Fasted S. acanthius maintained nearly
constant plasma TMAO levels over a 41-day trial (Cohen et al. 1958; Wood et al.
2010) and fasted winter skate (Leucoraja ocellata) maintained constant plasma
TMAO over a six-week period (Treberg and Driedzic 2006). During prolonged
fasting, neither study detected appreciable levels of TMAO production.
Compounded with low TMAO excretion rates, the authors concluded that TMAO
must be highly conserved during between-meal periods. While TMAO is likely
very well-conserved given its importance as an osmolyte, it seems unlikely that
efficient retention is the only mechanism for regulating TMAO. For example, the
ability to oxidize TMA has not yet been demonstrated in many species including
Rajiformes, which includes the family Dasyatidae (Treberg et al. 2006), a finding
that is particularly surprising given that Dasyatidae includes a number of
euryhaline species. TMAO has, however, been shown to increase in D. sabina
(Ferer 2007) and juvenile bull shark (Carcharhinus leucas) (Pillans et al. 2006)
with increasing salinity even in the absence of dietary inputs. Thus, even though
no mechanism of TMAO synthesis has been identified among the Dasyatidae
stingrays, D. sabina can increase plasma TMAO by some currently unidentified
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mechanism. As suspected by Seibel and Walsh (2006), this suggests that TMAO
can be synthesized endogenously in elasmobranchs.
Despite the evidence for endogenous TMAO synthesis, the method of
synthesis in elasmobranchs is still unknown. Treberg and Driedzic (2006)
reported evidence of FMO activity but were unable to demonstrate TMA oxidation
in vivo and in vitro in winter skate (Leucoraja ocellata). Goldstein and
Funkhouser (1972) demonstrated conversion of 14C-TMA and 14C-choline to 14CTMAO in nurse sharks in vivo through a putative Tmase or FMO enzyme. Given
that conversion of choline to TMA, the precursor to TMAO, is only known to occur
through microbial oxidation (Marzo and Curti 1997), the authors hypothesized
that intravenously injected 14C-choline must cross the intestinal lumen; once in
the gut, microbiota would convert 14C-choline to 14C-TMA, which could then be
converted by Tmase in the liver to 14C-TMAO. However, because Goldstein and
Funkhouser (1972) also demonstrated the conversion of

14C-choline

to 14C-

TMAO in liver homogenates in vitro, the authors assumed that their initial
hypothesis regarding bacterial 14C-choline to 14C-TMA was incorrect. Based on
evidence of symbiont bacteria living in liver tissue (Grimes et al. 1984, 1985;
Knight et al. 1988), it is possible that bacteria within the liver are able to convert
choline to TMA similar to bacteria within the gut. Additionally, experimental
manipulations of choline consumption in mammals indicate that intestinal
bacteria have a critical threshold for choline and thus are limited in their ability to
synthesize TMA (Ziesel et al. 1989). In elasmobranchs, additional populations of
endogenous bacteria within the liver could remediate the overload of choline in
11

the intestine: another possible benefit of symbiont microbes to the elasmobranch
host. Given the conflicting evidence for elasmobranch Tmase and FMOs,
exploring the potential for a bacterial role in TMAO synthesis via TMA oxidation
within the gut and other elasmobranch tissues is clearly warranted.
Experimental Design
Exploring this novel relationship between elasmobranchs and their
symbiont microbes will elucidate key physiological processes in elasmobranch
fishes. Because elasmobranchs rely on protein-toxic urea as an osmoregulatory
compound and, subsequently, TMAO to counteract the effects of urea toxicity, I
would expect elasmobranchs to possess urease and Tmase. However,
elasmobranchs do not appear to possess either of these enzymes, which
indicates the existence of alternative mechanisms for urea and TMAO regulation.
I hypothesize that intestinal microbes are responsible for the regulation of vital
osmoregulatory metabolites in elasmobranchs. This would indicate that microbial
nutrient cycling has profoundly influenced elasmobranch physiology, a finding
that would substantially change the perception of elasmobranch-microbe
relationships.
Establishing gnotobiotic individuals would be an ideal method to study the
influence of tissue and gut bacteria on elasmobranch physiology; however,
creation of gnotobiotic elasmobranchs is outside of the scope of this research.
Gnotobiosis has been established in small mammalian, avian, and amphibian
model organisms (Baker and Ferguson 1942; Reynier 1959; Gordan 1960) as
well as a few key species of teleost, namely the zebrafish Danio rerio (Rawls et
12

al. 2004; Bates et al. 2006; Pham et al. 2008). However, the process of creating
gnotobiotic individuals is time-consuming and expensive, requiring sterile birthing
and rearing, sterile food and water, and a sterile tank environment (Reynier
1959) all of which is complicated by the reproductive strategies of elasmobranchs
and the difficulty of rearing elasmobranchs that are born in captivity. Additionally,
according to the current literature, there has been no successful generation or
use of gnotobiosis in an elasmobranch model. For these reasons, gnotobiotic
elasmobranchs were neither created nor obtained. Therefore, my goal
throughout these experiments was instead to significantly reduce the
elasmobranch microbial community using broad-spectrum antibiotics in vivo, an
accessible alternative to gnotobiosis (Reikvam et al. 2011). Given a significant
reduction in the intestinal microbiome, I then observed key osmolytes to
determine if this reduction in microbiota caused an osmoregulatory or
physiological response. Further, I chose to focus my efforts on reducing the
intestinal microbiome and not the tissue microbiome; a study of antibiotic efficacy
has never been published in elasmobranchs, thus delivery of targeted oral
antibiotics was more likely to succeed at reducing the intestinal microbiome than
antibiotics injected intravenously or intramuscularly. Additionally, intravenous
antibiotic injection could cause confounding results given the lack of published
studies of antibiotic effects on other aspects of elasmobranch physiology.
This study aims to answer these key hypotheses: (1) intestinal bacteria
are responsible for the catabolism of urea via urease; and (2) intestinal bacteria
are responsible for the production of TMAO. In summary, I investigated the
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potential involvement of endogenous bacteria in the ureosmotic strategy of
elasmobranch fishes in vivo by significantly reducing the intestinal bacterial
community and observing subsequent changes in metabolites and mRNA
expression of a key urea-cycle enzyme, CPS III. If bacteria are responsible for
TMAO production, I would expect a decrease in TMAO concentrations in
individuals treated with antibiotics. Additionally, if intestinal microbes are
responsible for urea hydrolysis, I would expect an increase in urea
concentrations or an increase in urea excretion, coupled with a decrease in urea
production (i.e. a decrease in CPS III expression) in antibiotic-treated animals.
This research will benefit future studies regarding the physiological importance of
the elasmobranch microbiome and the use of antibiotics in captive
elasmobranchs.
Model Organism
Dasyatis sabina is an ideal elasmobranch model for in vivo study because
(1) there is a large body of literature on D. sabina physiology, (2) D. sabina are
both eurythermal and euryhaline and can therefore tolerate a wide range of
temperatures and salinities, (3) saltwater populations are well-established and
readily available in the Gulf of Mexico, and (4) my lab is experienced with D.
sabina husbandry and thus D. sabina are relatively easy to maintain in captivity.
Given these unique characteristics, D. sabina is an appropriate as well as
abundant model animal to draw conclusions regarding elasmobranch
osmoregulatory strategy and the effects of antibiotics on the elasmobranch
intestinal microbiome.
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Figure 1. Elasmobranch ornithine-urea cycle.
The elasmobranch O-UC as depicted in a hepatic mitochondrion. Enzymes are displayed in pink, substrates in black, and
membrane transport proteins in blue. Enzyme abbreviations are listed as follows: glutamine dehydrogenase (GDHase),
glutamine synthetase (GSase), carbomoyl phosphate synthetase III (CPS III), ornithine transcarbamoylase (OTCase),
argininosuccinate synthase (ASS), argininosuccinate lysate (ASL), and arginase (ARGase).).

15

CHAPTER II – THE OSMOREGULATORY RESPONSE OF ATLANTIC
STINGRAY, DASYATIS SABINA, TO INTESTINAL MICROBIOME REDUCTION
Introduction
Marine elasmobranchs employ a unique osmoregulatory strategy in which
solutes – primarily nitrogenous compounds – are accumulated in the blood
plasma and tissues to counteract dehydration due to the osmotic pressure of
saltwater. The accumulation of nitrogenous compounds such as trimethylamine
n-oxide (TMAO) and urea (Smith 1936; Pang et al. 1977; Yancey and Somero
1979; Ballantyne et al. 1987) results in plasma that is iso- or slightly hyperosmotic with respect to saltwater. Of the total osmolytes present in elasmobranch
plasma, urea and TMAO account for roughly 60% of these solutes (Goldstein
and Funkhouser 1972; Ballantyne and Robinson 2010); thus, the importance of
these compounds for osmoregulation cannot be overstated. Without constant
maintenance of high concentrations of urea and TMAO marine elasmobranchs
will dehydrate, which is detrimental to organismal function and overall health.
Furthermore, without a method for conserving the nitrogen present in urea or
synthesizing TMAO elasmobranchs are entirely reliant on dietary sources for
these critical nitrogenous compounds. This poses a greater challenge for
euryhaline elasmobranchs such as the Atlantic stingray (Dasyatis sabina), which
travel freely between freshwater and saline environments and must rapidly alter
plasma solutes in response to changing salinity.
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However, despite the importance of these nitrogenous compounds to
osmoregulation, our understanding of urea and TMAO metabolism in
elasmobranchs is limited. Given the necessity for elasmobranchs to accumulate
large quantities of urea and TMAO, nitrogen retention is the most effective and
energetically efficient way for elasmobranchs to maintain osmolality, particularly
given that elasmobranchs are nitrogen-limited (Wood et al. 2005). Urease, the
enzyme responsible for hydrolysis of urea to ammonia, is a key step in ureanitrogen scavenging (UNS) and is strikingly absent in elasmobranchs (Wood
1950; Simidu and Oisi 1951; Knight et al. 1988). Similarly, there is conflicting
evidence for the presence of an elasmobranch-synthesized trimethylamine
(TMA) oxidizing enzyme, TMA oxidase (Tmase) or flavin-containing
monooxygenase 3 (FMO3), which is necessary for the production of TMAO
(Goldstein and DeWitt-Harley 1973; Seibel and Walsh 2002).
There is, however, evidence of urease and Tmase activity in multiple
bacterial taxa. Tmase or bacterial TMA monoxygenase (Tmm) has been
conclusively found in Methylocella silvestris (Chen et al. 2011) and
Pseudomonas strain P (Chandler 1983) – a species that was able to use TMA as
a sole nitrogen source – as well as species of marine and coastal bacteria
including Ruegeria pomeroyi and Citreicella sp. SE45 (Lidbury et al. 2015), which
have critical roles in ocean nitrogen cycles through the remineralization of
nitrogen in the form of ammonia. Additionally, homologous sequences of Tmm
have been identified in many marine bacterial taxa (Chen et al. 2011). Urease is
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not only common among bacteria (Mobley and Hausinger 1989), but has been
identified in bacteria within the elasmobranch microbiome (Grimes et al. 1984,
1985; Knight et al. 1988; Youngren-Grimes 1990) in addition to the intestinal
microbiome of other vertebrates (Wozny et al. 1977; Suzuki et al. 1979;
Robinson et al. 1981).
Because urease and Tmase or Tmm have yet to been identified in
elasmobranchs but are readily found in bacteria, I hypothesize that endogenous
microbes are primarily responsible for urease and TMA oxidation activity. Given
the importance of urea and TMAO to elasmobranch osmoregulation, if bacteria
are involved in elasmobranch osmolyte metabolism this will represent a novel
relationship previously unseen between aquatic vertebrates and microbes.
Further, this would suggest that elasmobranchs are dependent upon
endogenous microbes for key osmolyte synthesis and scavenging.
To test this microbe-osmolyte hypothesis in elasmobranchs, I
administered a broad-spectrum antibiotic cocktail to captive D. sabina and
quantified the resulting changes in osmolyte and metabolite concentrations in a
“bacteria-reduced” state over the course of two weeks. If bacteria were
responsible for urease activity (i.e. hydrolysis of urea to ammonia), I expected to
observe a cessation of urease activity and either an increase in plasma urea
concentration or an increase in expelled urea in antibiotic-treated (+AB)
individuals. I also explored the effect of bacterial population reduction on the urea
cycle by quantifying relative gene expression of the rate-limiting enzyme in the
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liver ornithine-urea cycle (O-UC), carbomoyl phosphate synthetase III (CPS III)
(Casey and Anderson 1985). If reduction in urea recycling indeed caused an
increase in urea concentration or excretion, I hypothesized that urea production
would be down-regulated in order to conserve nitrogen in animals with reduced
intestinal microbiota. Additionally, if bacteria were responsible for TMAO
production given no dietary input, I expected a cessation of TMA oxidase activity
and thus a termination of TMAO production in +AB individuals.
From the literature, in vivo studies of UNS using bacterial knockouts have
primarily focused on ruminants and their symbiont bacteria (Visek 1978) and this
topic has never been explored in an elasmobranch model. Additionally, bacteria
may colonize elasmobranchs tissues and thus the viability of creating a true
bacterial knockout is complex. This hypothesis is predicated on previous studies
by Grimes et al. (1984, 1985) and Mylniczenko et al. (2007), who found evidence
of endogenous bacteria residing in tissues and blood, respectively. Because I
can more readily guarantee the efficacy of antibiotics on intestinal bacteria, in
vivo study will focus on the effects of reducing bacteria in the intestines only. The
effect of intestinal bacterial reduction on TMA oxidation or urease activity in
elasmobranchs has never been studied in vivo. This experiment seeks to
determine the relationship between elasmobranchs and gut microbiota in the
absence of exogenous nitrogen inputs by reducing resident bacteria and
quantifying subsequent impacts on osmolyte concentration and O-UC enzyme
gene expression.
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Materials and Methods
In Silico Analysis of Urease and Tmase/FMO Nucleotide and Protein Sequences
Before exploring the possibility of bacterial urease activity in
elasmobranchs, the absence of an elasmobranch-synthesized urease enzyme
had to first be verified. Urease protein and nucleotide FASTA sequences (Table
A1) were aligned using the National Center for Biotechnology Information (NCBI)
Protein or Nucleotide Basic Local Alignment Search Tool, BLASTp 2.5.0 and
BLASTn 2.5.0, respectively (https://blast.ncbi.nlm.nih.gov/Blast.cgi) (Altschul et
al. 1997) and SkateBLAST (http://skatebase.org) (Wang et al. 2012; Wyffels et
al. 2014). Nucleotide and protein databases were searched for urease
sequences using the available NCBI taxonomic tree to first identify known
elasmobranch, chordate, and vertebrate urease sequences. Following this initial
search, urease sequences were selected from species of bacteria, fungi, and
plants: the most abundant urease-positive taxa. Using NCBI BLASTp and
BLASTn, urease protein and nucleotide sequences were aligned to
elasmobranch sequences (BLAST taxa ID: 7778) using the blastn algorithm for
“somewhat similar sequences”. In SkateBLAST, urease sequences were aligned
to the available Batoidea genome data from the little skate (Leucoraja erinacea);
transcriptome data from L. erinacae, small-spotted cat shark (Scyliorhinus
canicula); and the holocephalan elephant shark (Callorhinchus milii); in addition
to mitochondrial genomes and genes from L. erinacea, the thorny skate
(Amblyraja radiata), and the ocellate spot skate (Okamejei kenojei).
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This same procedure was used to identify an elasmobranch-synthesized
Tmase enzyme, however, this search was instead directed at FMOs after
searches for Tmase-specific nucleotide and protein sequences were
unsuccessful. Instead, nucleotide and protein sequences for FMO – the
vertebrate hepatic enzyme that monooxygenates compounds including TMA
(Lang et al. 1998) – were collected from various vertebrates (Table A2) and
aligned to known elasmobranch sequences using methods identical to those
used in urease alignments. mRNA sequences were aligned using NCBI tBLASTn
2.5.0 (https://blast.ncbi.nlm.nih.gov/Blast.cgi) (Altschul et al. 1997).
Animal Collection and Holding
D. sabina (n=16) were caught via trawl and hook-and-line in the
Mississippi Sound by the University of Southern Mississippi (USM) Center for
Fisheries Research and Development and the USM Marine Education Center, or
donated by local shrimp fisherman. D. sabina selection was not based on size or
sex because osmoregulatory strategies should be consistent across both sexes;
however, only mature individuals were selected because the rigors of the
experimental methods might negatively affect smaller individuals
disproportionally. Animals were treated for parasitic copepods for three days in a
500-gallon tank dosed with 12.5 mL Dimilin (Diflubenzuron N-[{(4Chlorophenyl) amino} carbonyl)-2, 6-difluorobenzamide) prior to transport to the
Gulf Coast Research Laboratory’s Marine Experimental Research Laboratory
(MERL), an enclosed, temperature-controlled facility (23-25oC) with a diurnal
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photoperiod that simulates natural conditions. Holding tanks were maintained at
20 ppt using Crystal Sea Marinemix® (Marine Enterprises International,
Baltimore, MD, USA) due to the capture conditions of the experimental D. sabina;
the salinity in the Mississippi Sound during the sampling period was ≤20 ppt.
Tank temperature, water quality, and pH were monitored daily to ensure
uniformity for the duration of the experiment. Water changes occurred in
response to elevated nutrients and pH. Animals underwent a general health
assessment and were allowed to acclimate to tank conditions for two weeks prior
to the start of the experiment. During acclimation, all animals were fed a diet of
locally caught shrimp twice daily until sated. Any uneaten food was removed from
the tanks within 15 minutes of feeding. Following the two-week acclimation
period, animals fasted for the duration of the experiment to control for dietary
inputs of nitrogen and ensure that all nitrogenous osmolytes were synthesized
endogenously.
Experimental Design
Experiments were carried out in accordance with the USM Animal Care
and Use Committee (IACUC protocol #15101510). At the MERL, animals were
divided into one of 18 tanks within three stand-alone recirculating systems
(Figure 2). Each of these three systems included a head tank, where a bio-filter
broke down harmful ammonium to nitrate, and six holding tanks. Water was
pumped from the head tank into each holding tank and then returned to the head
tank. Because water was treated by the bio-filter before flowing back to individual
22

Figure 2. Animal holding schematic
Schematic of the in vivo experimental design with antibiotic (+AB) and control tanks randomly distributed among three
stand-alone recirculating systems.
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tanks and each tank housed a single animal, each holding tank was treated as a
singular unit. Male (n=6) and female (n=11) D. sabina were distributed to
randomly assigned control (n=8) and experimental tanks (n=8). Every 24 hours,
animals were removed from their holding tanks and placed on a wet cloth on top
of a flat surface for subsequent weighing, blood draws, and antibiotic (+AB) or
placebo (control) dosing. Animals were weighed (kg) and blood was drawn from
each individual prior to the dosing on day one and again on day seven and day
14. Disc width was also measured on day 14. According to tank assignment,
animals were dosed with antibiotics or a placebo and then placed back in their
respective holding tanks. Time spent out of water was limited to two minutes.
At a minimum, 0.2 mL of blood was drawn from the dorsal wing using a
1mL syringe and 22-gauge needle and transferred to a heparinized Vacutainer®+
tube. Blood samples were then transferred into a 1.5 mL micro-centrifuge tube
and centrifuged at 5,000 rpm for 5 minutes to separate plasma from the cellular
blood components. Plasma supernatant was transferred into a separate tube,
immediately frozen on dry ice, and stored at -80C until further analysis.
Immediately following blood draw on day 14, animals were euthanized in
MS-222 (Tricaine methanesulfonate). Animals were necropsied with autoclavesterilized tools, which were cleaned with 95% ethanol between samples. Liver
samples (≤5 mm section) were collected immediately after sacrifice, flash-frozen

+

Vacutainer® is a registered trademark of Becton, Dickinson and Company
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on dry ice, and stored at -80C until further analysis. Whole intestines were
removed, rapidly divided into three distinct sections (duodenum, spiral valve, and
colon) using autoclave-sterilized hemostats, and placed in separate sterile Petri
dishes. The lumen-side of each section was scraped using a laboratory spatula,
placed into individual 1.5 mL microcentrifuge tubes, and immediately frozen on
dry ice. Intestinal scrapes were stored at -80C until further analysis.
Antibiotics
Because there are no published studies on antibiotic efficacy in
elasmobranchs, antibiotics were selected in consultation with Dr. Natalie
Mylniczenko, DVM and recent studies of the intestinal microbiome in mouse
models (Reikvam et al. 2011; Hill et al. 2010). Our protocol closely follows the
methods of Reikvam et al. (2011) with the exception of metronadizole, which was
eliminated because I was unable to achieve complete dissolution in water.
Additionally, this mixture served as a broad-spectrum antibiotic because each
chosen antibiotic targeted different bacterial groups: neomycin is an
aminoglycoside that affects gram-negative bacteria, ampicillin affects gramnegative and gram-positive bacteria by disrupting the ability of bacteria to
construct cell walls, and vancomycin affects gram-positive bacteria that are
unresponsive to ampicillin through a similar mechanism of action. Given that
species of bacteria from either group synthesize urease or Tmase enzymes, a
broad-spectrum approach to microbiome reduction was selected to reduce the
community of microbiota within the elasmobranch gut without solely targeting
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gram-negative or gram-positive bacteria. Control animals received a placebo
dose containing only autoclave-sterilized de-ionized (DI) water.
The antibiotic cocktail was made fresh daily and consisted of 100 mg  kg-1
animal weight Neomycin sulfate (Calbiochem), 100 mg  kg-1 animal weight
Ampicillin sodium salt (Alfa Aesar), and 50 mg  kg-1 animal weight Vancomycin
hydrochloride (VWR) dissolved in autoclave-sterilized DI water and administered
in volumes of 1 mL  kg-1 animal weight. Dosages were administered via oral
gavage inserted to an area between the gill slits and the stomach to maximize
antibiotic absorption to the intestine. Separate 14-gauge gavage needles and 3
mL sterile syringes were used for control and antibiotic groups with care taken to
remove all air from the syringe prior to administration. Gavage needles were
thoroughly cleaned with 95% ethanol between doses and stored in 95% ethanol
when not in use.
Plasma Osmolality and Osmolytes
Blood plasma urea (mmol/L), TMAO (mmol/L), and osmolality (mg/kg)
were measured using samples collected from each individual at day one, seven,
and 14. Aliquots containing 10 μL of plasma were diluted to 1:25 and urea was
quantified via colorometric assay (Quantichrom Urea Assay Kit, Biosystems
Systems). TMAO was quantified spectrophotometrically (Molecular Devices
SpectraMax M2) with aliquots of 15 μL of plasma following the iron-sulfate
method (Wekell and Barnett 1991) modified by Raymond (1998) for small plasma
volumes. Because TMA is negligible in elasmobranch plasma (Sulikowski et al.
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2003), TMA was not quantified. Osmolality was measured in 10 μL of plasma
from each sample using a Wescor VAPRO Vapor Pressure Osmometer (Model
No. 5520).
Aliquots of 20 μL plasma from a subset of control (n=4) and +AB (n=6)
individuals at day one and day 14 were sent to the West Coast Metabolomics
Center (University of California, Davis) for untargeted metabolomic analysis of
biogenic amines using published techniques for HILIC-ESI QTOF tandem massspectrometry (Feihn et al. 2011).
DNA Extraction
DNA was extracted from all frozen gut scrape samples using the DNeasy
Blood and Tissue kit (Qiagen, Valencia, CA). Following kit instructions for tissue
DNA extraction, 20 mg of scraped tissue was added to 180 μL of Buffer ATL with
20 μL proteinase K. Samples were vortexed and incubated at 56ºC for 30
minutes before proceeding with spin column purification as outlined in the
manufacturer’s protocol. Extracted DNA was quantified and verified for purity
spectrophotometrically using a Thermofisher Nanodrop (ND-2000). DNA was
then frozen at -80C until further analysis.
RNA Extraction and cDNA Synthesis
Because urea is primarily synthesized in the liver, hepatic tissue was
selected as the target tissue for CPS III expression (the rate limiting enzyme in
the O-UC). RNA was extracted from 25 mg liver tissue per sample, which was
homogenized manually with microcentrifuge tube pestles in 500 μL TRIzol
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reagent (Invitrogen Corp., Carlsbad, CA). RNA was then extracted using phenolchloroform following the manufacturer’s protocol for RNA isolation. Following
isolation, 10 μg RNA per sample was purified and concentrated using Zymo
Clean and Concentrator columns with DNase I treatment (Zymo Research,
Orange, CA). The sample with the lowest RNA yield was used to determine the
maximum amount of RNA used for cDNA synthesis, therefore, 0.54 μg purified
and DNase-treated RNA from each sample was used to synthesize cDNA. Per
reaction, 0.54μg RNA was combined with 0.5 μg random primers adjusted to a
final volume of 5 μL. RNA and primers were heated to 70C for 5 minutes, then
placed on ice until addition of reverse transcription (RT) mix. RT mix consisted of
4 μL 5X Go Script Reaction Buffer, 4 μL MgCl2, 1 μL PCR nucleotide mix, 0.5 μL
Recombinant RNasin Ribonucleotide Inhibitor, 1 μL GoScript Reverse
Transcriptase, and 4.5 μL nuclease-free water per reaction (Promega, Madison,
WI, cat. no. A5000). For each reaction, 15 μL of RT mix was combined with 5 μL
of RNA and random primers. RT reactions were carried out as follows: 5 minutes
annealing at 25C, 60 minutes extension at 42C, followed by reverse
transcription inactivation at 70C for 15 minutes. Liver cDNA was stored at -20C
until further analysis.
qRT-PCR
Quantitative real-time PCR (qRT-PCR) was performed using PowerUp
SYBR Green (Applied Biosytems) to determine the efficacy of antibiotics at
reducing the microbiome in +AB individuals and the expression of CPS III in liver
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tissue. From each gut scrape DNA or liver cDNA sample, 2 μL of DNA or cDNA
was added to 18 μL PowerUp SYBR Green master mix (A25742, Applied
Biosystems), which included 10 μL of PowerUp SYBR Green master mix, 1 μL of
forward primer at 5 μM, 1 μL of reverse primer at 5 μM, and 6 μL of nuclease-free
water per reaction. Relative bacterial quantity was assessed in gut scrape DNA
using a bacterial target gene (16S V2 region) and a host control gene (fish actin)
(Table A3) following similar protocols in mice (Reikvam et al. 2011). CPS III gene
expression was assessed in liver cDNA using CPS III primer sequences
identified by the Evans laboratory (unpublished data) and 18S as a control gene
(Table A4). Each reaction was run in triplicate to verify reading accuracy on
MicroAmp Fast Optical 96-well reaction plates (Applied Biosystems) sealed with
optical adhesive film (VWR). qRT-PCR conditions were performed and analyzed
using a 7500 Fast Real-Time PCR System (Applied Biosystems) and proceeded
as follows: an initial denaturation cycle at 50C for 2 minutes and 95C for 2
minutes, 40 cycles at 95C for 15 seconds and 60C for 1 minute, followed by a
dissociation curve.
Statistical Analysis
After assessment for homogeneity and normality of variance, changes in
measured osmolytes and animal weight between groups (control and +AB) and
between time points (day one, seven and 14) were assessed using a two-factor
repeated-measures analysis of variance (ANOVA). Any analysis yielding a pvalue <0.05 was considered statistically significant. A post-hoc t-test for paired
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two-sample means was performed on all ANOVA tests for which the null
hypothesis was rejected.
qRT-PCR results for liver tissue CPS III expression and gut microbiome
reduction were analyzed first with an F-test to determine equality of variance
between control and antibiotic groups. After verification of variance equality, ttests of ∆Ct values (Yuan et al. 2006) were used to determine significant
expression differences between control and +AB groups.
Because of the unbalanced number of individuals in control (n=4) and +AB
(n=6) groups, an ANOVA could not be performed on the metabolomics data.
Instead, both groups were analyzed separately using paired analyses to detect
significant differences between plasma metabolites at day one and day 14.
Variables that were significantly different in the control group were considered to
be caused by starvation and variables that were significant only in the +AB group
were considered to be a result of antibiotics and/or a reduction in the host
microbiome. Using the peak intensity table generated by the West Coast
Metabolomics Center, metabolites were filtered based on interquartile range to
eliminate metabolites unlikely to provide significant results. Metabolomics data
was then normalized by sum to reduce concentration-related differences and
Pareto-scaled (mean-centered and divided by the square root of the standard
deviation of each metabolite) to compare all metabolites regardless of absolute
value. Filtered and normalized values were analyzed using MetaboAnalyst 3.0
(http://www.metaboanalyst.ca; Xia et al. 2015), a website that allows users to
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interrogate metabolomics data for significantly different metabolites using t-tests,
calculate fold-change of metabolites, and generate volcano plots. In this study, I
used paired tests for all analyses with a fold change threshold of 2.0 and α = 0.05
representing statistically significance.
Results
In Silico Analysis of Urease and FMO Nucleotide and Protein Sequences
All alignments for urease nucleotide or protein within known elasmobranch
sequences yielded no meaningful alignment results even with the broadest and
most forgiving search parameters. All positive hits for elasmobranch nucleotide
or protein sequences in either database had 0-1% query cover with all aligned
sequences (Table A1) and were short fragments of <40 base pairs per alignment
or <20 amino acids. Additionally, all positive hits had <63% identity, which is
significant given the average full urease sequence length is >5,000 base pairs
and >500 amino acids. This was true of all urease nucleotide and protein
sequences interrogated with all available elasmobranch genomes,
transcriptomes, and mitochondrial genome sequences.
Search for an elasmobranch-synthesized FMO yielded promising, though
inconclusive, results. SkateBLAST alignments of the holocephalan C. milii NCBIpredicted FMO mRNA (NCBI Ref. Seq. XP_007887552.1) with the S. canicula
transcriptome identified high-identity, low-query cover fragments (<100 bp
fragments with ≤71% similarity). The predicted FMO protein sequence from C.
milii did not, however, produce significant alignment results with any
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elasmobranch sequences in either NCBI or SkateBASE. To identify the likelihood
that the NCBI-predicted C. milli FMO sequence is indeed an FMO, C. milii
sequences were aligned with the sequences of other vertebrate FMOs. C. milli
FMO mRNA had high-identity, low-query cover alignment with African clawed
frog (Xenopus laevis) predicted FMO sequence (5% query cover with 75%
identity). Additionally, the predicted C. milii FMO protein sequence aligned with
three predicted FMO protein sequences from the West Indian Ocean coelacanth
(Latimeria chalumnae) (58% identity with 98% query cover), tongue sole
(Cynoglossus semilaevis) (48% identity with 97% query cover), D. rerio (48%
identity with 98% query cover) as well as the O. mykiss FMO protein (37%
identity with 86% query cover). Further, alignment of the O. mykiss FMO
nucleotide sequence produced high-identity, low-query cover alignments with the
L. erinacea transcriptome (<100 bp fragments with ≤93% similarity). All broad
FMO nucleotide and protein queries within the NCBI database returned no
significant results and positive results were limited to short fragments of <40 base
pairs or <20 amino acids per alignment.
Antibiotic Efficacy
Efficacy of antibiotics was measured based on relative quantification of the
V2 region of 16S rRNA present in tissue scrapes from three different regions of
the intestinal tract: duodenum, spiral valve, and colon. Following the methods
outlined by Yuan et al. (1998), ∆Ct values were compared between +AB and
control groups to determine significant changes in relative expression of 16S
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rRNA. Fold change was calculated using 2-∆∆Ct values. Using an antibiotic
cocktail of neomycin, vancomycin, and ampicillin, the total bacterial load in D.
sabina was significantly reduced in the spiral valve (F-test: p=0.80; t-test
assuming equal variance: p-value=0.03) (Figure 3) and the colon (F-test: p=0.62;
t-test assuming equal variance: p-value=0.003) (Figure 3). The bacterial
community in the duodenum was the only region of the intestine in which
antibiotics did not significantly reduce the total bacterial load (F-test: p=0.76; ttest assuming equal variance: p-value=0.15) (Figure 3).

Relative 16S (V2) rRNA expression
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Figure 3. Efficacy of antibiotics in D. sabina intestine
Note: 16S rRNA (V2 region) mRNA fold changes (control:antibiotic) in D. sabina duodenum, spiral valve, and colon in
control and +AB animals. Values marked with an asterisk (*) or two asterisks (**) are significantly different from control
animals (t-test, p<0.05 and p<0.01, respectively).
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Animal Weight and Plasma Osmolytes
Plasma osmolytes did not change significantly over the course of the
experiment, nor was there a significant difference between D. sabina dosed with
antibiotics and a placebo. Plasma osmolality (two-factor repeated-measures
ANOVA, F=0.48, p=0.22) (Figure 4), urea concentration (two-factor repeatedmeasures ANOVA, F=0.63, p=0.43) (Figure 5), and TMAO concentration (twofactor repeated-measures ANOVA, F=0.63, p=0.44) (Figure 6) were not
significantly altered by antibiotics or the two-week experiment period. However,
animal weight did significantly change over two weeks (two-factor repeatedmeasures ANOVA, F=4.04, p=0.03) (Figure 7). Using a post hoc t-test for paired
two-sample means, D. sabina weight was significantly different between day one
and day 14 in both control (p=0.03) and antibiotic (p<0.001) groups.
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Figure 4. Plasma osmolality
Note: D. sabina blood plasma osmolality (mOsm) over two-weeks of in vivo antibiotic or placebo (control) dosage.
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Figure 5. Plasma urea concentration
Note: D. sabina blood plasma urea (mM) over two-weeks of in vivo antibiotic or placebo (control) dosage.
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Figure 6. Plasma TMAO concentration
Note: D. sabina blood plasma TMAO (mM) over two-weeks of in vivo antibiotic or placebo (control) dosage.
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Figure 7. Animal weight
Note: D. sabina weight (kg) over two-weeks of in vivo control and +AB animals.

Metabolomics
Of the 477 metabolites measured in D. sabina plasma between the
beginning and end of the two-week in vivo experiment, 32 metabolites
significantly changed among control D. sabina (paired t-test, p<0.05) (Figure 8)
(Table 1) and 35 metabolites among antibiotic-treated D. sabina (paired t-test,
p<0.05) (Figure 9) (Table 2). Within the control group, 27 significantly changed
metabolites were unique to the control group and 30 were unique to the antibiotic
group. However, many of these metabolites are unidentified thus no further
conclusions can be drawn about their importance to overall elasmobranch
physiology and metabolism at this time; the remainder of this analysis will focus
on known metabolites. Creatinine and L-citrulline changed significantly in control
D. sabina plasma: creatinine abundance increased (t3=3.76, p=0.03) and L36

citrulline decreased (t3=-3.72, p=0.03). In the antibiotic group, there was a
significant increase in 1,2-diamino-2-methylpropane (t5=3.63, p=0.02) and a
significant decrease in arginine (t5=-2.63, p=0.05). Benzoic acid is another
metabolite of note, which is the only identified metabolite that significantly
increased in D. sabina regardless of antibiotic dosage. Further, +AB D. sabina
experienced a greater increase (4,049-fold change ± 3,163) in benzoic acid than
control individuals (800-fold change ± 421).

37

Figure 8. Heatmap of significant metabolites in control D. sabina
Note: D. sabina control (n=4) metabolites that changed significantly (p<0.05) between day one (under the red bar) and
day 14 (under the green bar).

Table 1
Significant metabolites in control D sabina
Metabolite

t stat

p value

1.40_266.18*

8.83

0.003

2.60_122.07*

8.30

0.004

1.04_166.09*

7.41

0.005

8.53_151.05*

7.28

0.005

4.72_227.12*

6.43

0.008

8.20_236.14*

5.97

0.009

7.96_261.14*

5.13

0.014

8.14_129.07*

4.95

0.016

9.05_185.13

-4.74

0.018

7.33_244.11*

4.67

0.019

9.88_223.99*

4.49

0.021

8.60_159.15*

4.48

0.021

9.23_161.13

-4.44

0.021

9.88_265.02*

4.42

0.021

9.46_170.09*

4.39

0.022

8.59_190.12

4.20

0.025

Note: significant metabolites unique to the control group are marked with an asterisk (*).
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Table 1 (continued).
9.39_351.24*

4.18

0.025

1.42_641.31*

3.93

0.029

4.53_257.11*

3.78

0.032

6.88_120.08*

3.76

0.033

Creatinine MH*

3.76

0.033

L-Citrulline*

-3.72

0.034

8.52_84.04_8.52_101.07*

3.61

0.036

8.20_869.23*

-3.53

0.039

9.04_369.25

-3.47

0.040

6.88_160.10*

3.43

0.042

8.48_198.12_8.48_220.11*

3.41

0.042

Benzoic acid, 3-amino- MH

3.34

0.044

5.08_116.11*

3.23

0.048

9.50_177.12*

3.21

0.049

1.44_583.26*

3.21

0.049

4.75_172.12*

3.21

0.049

Note: significant metabolites unique to the control group are marked with an asterisk (*).
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Figure 9. Heatmap of significant metabolites in +AB D. sabina
Heatmap of +AB D. sabina (n=6) blood plasma metabolites that changed significantly (p<0.05) between day one (under
the red bar) and day 14 (under the green bar).
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Table 2
Significant metabolites in +AB D. sabina
Metabolite

t stat

p value

9.39_523.34*

-15.92

1.78E-05

7.34_215.06*

6.19

0.002

6.19_537.17*

-5.58

0.003

6.60_137.05*

-4.25

0.008

7.42_241.16*

-4.19

0.009

8.80_203.15*

-4.03

0.010

9.34_771.87*

-3.82

0.012

9.23_161.13

-3.77

0.013

9.34_772.37*

-3.76

0.013

1.32_151.14*

3.75

0.013

1,2-Diamino-2-methylpropane MH_noMSMS*

3.63

0.015

9.39_349.23*

-3.62

0.015

9.39_175.24*

-3.50

0.017

1.45_437.24*

3.47

0.018

6.96_287.20*

-3.47

0.018

1.64_115.09*

3.43

0.019

1.43_603.34*

3.39

0.020

7.97_176.13*

-3.38

0.020

Note: significant metabolites unique to the +AB group are marked with an asterisk (*).
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Table 2 (continued).
1.43_585.32*

3.32

0.021

6.19_559.15*

-3.28

0.022

8.67_116.03*

-3.25

0.023

Benzoic acid, 3-amino- MH

3.12

0.026

8.03_356.08*

-2.99

0.030

1.43_311.20*

2.95

0.032

8.75_159.08_8.75_176.10*

-2.88

0.034

9.73_257.68*

2.85

0.036

9.14_189.16*

-2.78

0.039

1.45_305.16*

2.77

0.039

1.43_589.33*

2.76

0.040

9.04_369.25

-2.64

0.046

7.84_231.17*

-2.64

0.046

Arginine MH*

-2.63

0.047

9.05_185.13

-2.62

0.047

9.31_205.15*

-2.60

0.048

8.59_190.12

2.60

0.048

Note: significant metabolites unique to the +AB group are marked with an asterisk (*).

CPS III Expression in Dasyatis sabina Liver
Relative expression of CPS III was quantified in liver cDNA using ∆Ct
cvalues between control and antibiotic groups (Yuan et al. 1998). Fold change
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results were calculated using 2-∆∆Ct values. Expression of CPS III in the liver was
significantly reduced in D. sabina dosed with antibiotics (F-test: p=0.28; t-test:
p=0.02) (Figure 10).

Relative CPS III mRNA expression

1.6
1.4
1.2
1
0.8
*

0.6
0.4
0.2
0
Control

Antibiotic

Figure 10. Liver CPS III expression
Expression fold change of CPS III mRNA in D. sabina liver tissue in control and +AB animals. Values marked with an
asterisk (*) are significantly different from control animals (t-test, p<0.05).

Discussion
This is the first study to demonstrate an effective method of reducing the
intestinal microbiome and to subsequently explore the effect of an altered gut
microbiome on osmoregulation in vivo. Additionally, I provide the first evidence
that urease and Tmase or an FMO may be absent in elasmobranchs using an in
silico analysis. This is also, according to current literature, one of only three
examples of a metabolomic approach to evaluate elasmobranch health and
physiology: the whale shark (Rhincodon typus) metabolome was published by
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Dove et al. (2012) and a preliminary metabolomic study on the influence of air
exposure on D. sabina was published by Lambert (2014). Given the efficacy of
the antibiotics used in this study, if there is a link between the metabolic
processes of gut bacteria and key osmolytes in elasmobranchs I would expect a
reduction in the elasmobranch intestinal bacterial assemblage to effect osmolyte
concentrations. The use of starved D. sabina is particularly compelling because
in the absence of dietary nitrogen input, all osmolytes must be synthesized,
maintained, and catabolized endogenously.
Antibiotic Efficacy
Using an antibiotic concoction of neomycin, vancomycin, and ampicillin, I
demonstrated a significant reduction in spiral valve and colon microbiota in +AB
D. sabina. While I did not observe a significant reduction in the bacterial load in
the duodenum, the abundance of bacteria in the duodenum is considerably lower
than that of the distal portion of the intestine (Gorbach 1996; O’Hara and
Shanahan 2006). Interestingly, the number of bacteria in the duodenum (10 1 103 viable cells · mL-1) is roughly equivalent to the number of bacteria found in
the stomach (Gorbach 1996; O’Hara and Shanahan 2006) and is thought to be
due at least in part to the proximity of the proximal intestine to the highly acidic
stomach environment. In comparison, the number of bacteria found in the distal
portions of the gut and the colon is between 1011 - 1012 viable cells · mL-1
(Gorbach 1996; O’Hara and Shanahan 2006). As such, I considered these
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antibiotics effective at reducing the overall microbiome of the elasmobranch
gastrointestinal tract.
Though antibiotic-treated animals did lose a significant amount of weight
over two weeks, they did not proportionally lose more weight than the control
group. Thus, weight loss is likely solely due to food restriction and not
compounded by the use of antibiotics. This is an important observation when
considering the implementation of antibiotics per os in captive elasmobranchs.
This study is the first published demonstration of antibiotic efficacy in
elasmobranchs and indicates that this combination, dosage, and method of
antibiotic delivery could be used in future investigations of microbiome-reduced
D. sabina.
Osmolytes and Osmolyte Metabolism
Before beginning in vivo study, I explored the possibility of an
elasmobranch-synthesized urease enzyme in silico by aligning urease
sequences (Table A1) to known elasmobranch genome databases. Despite
utilizing the broadest search parameters, no significantly homologous nucleotide
or protein sequence was identified within available elasmobranch genomes. This
analysis will remain somewhat incomplete until an entire elasmobranch genome
is published, however, the absence of urease in elasmobranchs is not surprising
given that a urease enzyme is not found in other vertebrate taxa. Therefore, any
urease activity in elasmobranchs is unlikely to be the result of an elasmobranchsynthesized enzyme. Instead, I propose that any urease activity in
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elasmobranchs is due to the presence of microbial enzymes. This assumption
does not come without precedence: in the gut of ruminants, bacteria in the rumen
recycle urea-nitrogen into ammonia, which can then be used as a nitrogen
source by other rumen bacteria (Bryant 1959; Mobley and Hausinger 1989;
Lapierre and Lobley 2011). Additionally, antibiotics have been shown to interrupt
microbial UNSg in the rumen (Prescott 1953; Muscher et al. 2010).
Despite a significant reduction in bacterial populations I did not observe a
significant increase in plasma urea concentrations over time. This could be due
to a number of compensatory factors, including an increase in urea excretion, a
decrease in urea production, or a combination of these two factors. I did not
quantify urea excretion given (1) the complexity of urine dilution in the aquatic
environment and (2) to avoid trauma caused by catheterization in vivo, however,
an increase in urea excretion could explain the consistent urea concentrations
found in antibiotic-treated D. sabina. Due to the high levels of urea found in the
proximal portion of the elasmobranch gut (Anderson et al. 2009), it is possible
that – in the absence of urease – urea cannot be converted to ammonia, which
cannot be transported out of the intestine via ammonia transporter, and is
excreted as a consequence to maintain steady plasma concentrations.
Alternatively, expression of urea transporters in the proximal intestine could be
down-regulated to conserve urea, which may be particularly important in starved
animals. Determining the expression of urea and ammonia transporters in the
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duodenum, spiral valve, and colon of antibiotic-treated animals would be an
interesting area of future study.
It is also possible that urea was not transported to the intestine due to a
shift in concentration gradient. Studies in ruminants demonstrated a significant
decrease in urea diffusion into the rumen when the microbial load was reduced,
indicating that microbial urea metabolism may provide a urea-diffusion
concentration gradient that is interrupted during antibiotic treatment (Houpt and
Houpt 1968; Cheng and Wallace 1979). Additionally, during times of low protein
consumption, ruminant urea excretion via urine decreased disproportionally – an
84% decrease in urea excretion with only a 57% reduction in protein (Tebot et al.
2002) – due to increased urea reabsorption in the kidneys (Ergene and Pickering
1978; Leng et al. 1985). This urea-nitrogen balance between host and microbe
might also modulate the response of D. sabina to decreased dietary nitrogen
inputs and possibly the effect of antibiotics: the “critical threshold” of the
elasmobranch microbiome could be lower than even the significant bacterial
reduction demonstrated by this study. Thus, D. sabina could have maintained
homeostatic osmolyte concentrations through compensatory mechanisms by
both the host and the microbiome.
This regulation and return to homeostatic conditions by the host is
supported by the quantification of CPS III mRNA abundance in the liver of control
and +AB D. sabina. I found that CPS III mRNA was significantly less abundant in
+AB animals, which, given that CPS III activity is a proxy for the rate of urea
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synthesis by the O-UC, implies a decrease in hepatic urea synthesis. This could
also be explained by a decrease in UNSg via microbial urease, which caused an
accumulation of urea-nitrogen in elasmobranch tissue and thus, a reduction in
requisite urea production. Indeed, in little skate (Raja erinacea) exposed to
decreased salinity, a decrease in hepatic CPS III activity coincided with an
increase in urea excretion due to a salinity-driven decrease in required urea
concentration (Steele et al. 2005). It is also possible that combination of both
mechanisms (i.e. an increase in urea excretion and a decrease in urea
production) are involved: urea could initially accumulate leading to an increase in
urea excretion which could subsequently be counteracted by a decrease in urea
production.
The existence of an elasmobranch-synthesized Tmase or FMO was also
explored using an in silico analysis with the sequences outlined in Table A2.
FMO has been identified genetically in the euryhaline teleost O. mykiss,
however, this enzyme has not been identified in elasmobranch taxa using
modern genetic techniques. Instead, expression of putative FMO has been
passively identified by precursor conversion to TMAO in vitro (Baker et al. 1963;
Goldstein and Funkhouser 1972; Goldstein and Dewitt-Harley 1973). As I
proposed, given the absence of antibiotics in the incubation media in these
studies, TMA oxidation could be due to bacterial enzymes that are still active in
vitro and not the result of elasmobranch FMO3 activity. In silico, I found possible
evidence of an elasmobranch-synthesized FMO protein. Though high-identity
48

sequences were relatively short fragments (<100bp), it is certainly possible that
these fragments are part of an elasmobranch FMO. However, even with
successful cloning of the elasmobranch FMO gene, further verification would be
required in order to ensure that this FMO can, in fact, synthesize TMAO: an indepth procedure that is outside of the scope of this research. However, these
findings in silico suggest that existence of an elasmobranch FMO is possible and,
given that the FMO3 isoform synthesizes TMAO in other vertebrates, could
indicate endogenous TMAO production in elasmobranchs. The existence of this
elasmobranch FMO clearly warrants further investigation.
Similar to urea, TMAO did not change significantly in D. sabina over two
weeks given antibiotics and lack of food, although – as in the case of urea –
there are a number of explanations for this finding. Elasmobranchs could be
robust to perturbations in the microbiome or antibiotics did not significantly
reduce specific portions of the bacterial assemblage, namely urease- and
Tmase-positive bacteria (i.e. the proposed “critical threshold” of the
elasmobranch microbiome). If this “critical threshold” of bacteria is required for
biologically-appreciable Tmase function, it is possible that I did not sufficiently
reduce Tmase-positive microbiota in order to see a reduction in enzyme activity.
Also, given the evidence of bacterial communities endogenous to elasmobranch
tissues such as liver, kidney, muscle, (Grimes et al. 1984, 1985) and blood
(Mylniczenko et al. 2007) bacteria within tissues could provide the requisite
urease and Tmase activity in the event of intestinal microbiome perturbations. It
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is also possible that +AB individuals had already reached a steady-state of urea
and TMAO excretion and retention after day seven, in which case I would not
have observed any significant difference in osmolyte concentrations. It is
surprising that this steady-state continued for 14 days in starved animals given
antibiotics, however, Wood et al. (2010) found that fasted S. acanthias
maintained plasma urea over 56 days at the expense of muscle nitrogen. The
effects of antibiotics immediately following administration in addition to
conducting experiments longer than 14 days should be explored in future
research. Additionally, salinity challenges presented to antibiotic-treated D.
sabina could be used to test the ability of microbiome-reduced individuals to
respond to increased salinity (e.g. increased pressure to elevate plasma
concentrations of both urea and TMAO).
Metabolites
From metabolomic analysis, I found a significant increase in benzoic acid
in both control and +AB animals over the course of two weeks. Benzoic acid is
found in berries and food preservatives – an unlikely source for elasmobranchs –
and is produced by phenylalanine and plant polyphenol metabolism in gut
bacteria. Phenylalanine metabolism seems an unlikely source of benzoic acid
given the lack of food and the low abundance of phenylalanine (<0.3mM) in
elasmobranch tissues to date (Ballantyne 1997). An increase in plant
polyphenols also seems an unlikely source given the absence of dietary inputs,
however, there is evidence of varying concentrations of polyphenols in ray liver
50

oil (Sellami et al. 2014). Degradation of polyphenols and other components of the
liver during periods of starvation could account for the substantial increase in
benzoic acid concentration. As an interesting aside, an increase in polyphenol
intake has been correlated with an improvement in non-alcoholic fatty liver
disease (Rodriguez-Ramiro et al. 2015). Polyphenols may play an interesting role
in elasmobranchs given the high abundance of lipids in the liver (Hayashi and
Kishimura 2000; Sellami et al. 2014). Additionally, an increase in benzoic acid
could occur due to shifts in gut microbiota community composition toward
bacteria that are more efficient at degrading polyphenols (Ktsoyan et al. 2011).
Benzoic acid is also the intermediary to many secondary metabolites, which
could indicate that metabolic activity is not proceeding efficiently in starved
animals. Additionally, hippurate formation – the excreted conjugate of benzoic
acid and glycine – is limited to the availability of glycine, a protein precursor that
could be limited by starvation conditions and thus limit the excretion of benzoic
acid.
In control animals, creatinine increased and L-citrulline decreased
significantly. An increase in creatinine could be due to the breakdown of creatine
in muscles due to starvation, however, this same increase was not seen in
antibiotic animals that also experience starvation. Among its many functions, Lcitrulline is a substrate in the O-UC that is synthesized from carbomoyl
phosphate and ornithine. L-citrulline is also associated with intestinal
functionality: in humans, a decrease in citrulline is indicative of a decrease in
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nutrient absorption from the intestine and intestinal failure and could also be
indicative of late-stage renal disease or dysfunction (Crenn et al. 2000) as
creatinine is cannot be eliminated from the blood. Interestingly, in human
subjects with endotoxemia – the presence of endotoxins produced from gramnegative bacteria in the blood – during calorie restriction caused a decrease in
citrulline (Poeze et al. 2010). This could indicate that control animals are
immuno-compromised by the in vivo conditions, which is further exacerbated by
calorie restriction allowing otherwise commensal bacteria to proliferate at the
detriment of the elasmobranch host. Interestingly, this same decrease was not
observed in fasted S. acanthias (Wood et al. 2010) even after 56 days, however,
this could be due to the low concentrations of citrulline present in elasmobranch
plasma even pre-starvation.
In D. sabina treated with antibiotics, I observed a significant increase in
1,2-diamino-2-methylpropane and a decrease in arginine. Though not much
information is available regarding 1,2-diamino-2-methylpropane, it may be an
intermediate of amine synthesis. A significant increase could indicate that amine
synthesis is not proceeding efficiently and to completion. Arginine is a substrate
in the synthesis of urea and ornithine in the O-UC and is critical for ammonia
detoxification. Depletion could indicate that arginine was consumed during the
process of urea generation, however, this contradicts my earlier finding that CPS
III – the rate limiting O-UC enzyme – is down-regulated. Possibly, prolonged
starvation and the absence of UNSg from intestinal bacteria caused an increase
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in urea production over time, but arginine stores were exhausted by day 14.
Starvation conditions seem a likely explanation as Wood et al. (2010) found a
significant decrease in arginine in fasted S. acanthias after five days. Possibly,
this increase was not observed in control animals due to increased nitrogen loss
in antibiotic-treated animals.
Conclusions
This study provides compelling future directions for microbiome and
metabolomic studies in elasmobranchs. Given the evidence for UNS in other
vertebrates and in elasmobranch liver tissue, this is the first study of
elasmobranch microbial urease activity in vivo and the only exploration of the
elasmobranch amine metabolome. Despite compelling evidence for microbial
urea metabolism in other vertebrate taxa and evidence of TMAO synthesis in
starved elasmobranchs given the conflicting evidence for an elasmobranchsynthesized Tmase enzyme, the observations of this study suggest that the
elasmobranch osmoregulatory strategy is robust to perturbations of the
microbiome. I postulate that this is due to compensatory mechanisms in
elasmobranch hosts, primarily osmolyte conservation. I also demonstrated
significant changes in 32 and 36 amine metabolites in control and antibiotic,
respectively, during starvation conditions and antibiotic treatment. The
association between bacterial metabolites and elasmobranch osmolytes
represents a unique relationship that warrants in-depth future study.
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APPENDIX A – Tables
Table A1.
Urease sequences queried
Organism

Accession number
Nucleotide

Protein

Agaricus bisporus f

AJ748112.1

—

Arthroderma benhamiae f

AB304404.1

—

Bacillus subtilis b

Y08559.1

—

Brucella abortus b

—

Q2YPD5.1

Campylobacter pylori b

—

P69996.1

AB479194.1

—

U81509.3

—

JN001915.1

—

Corynebacterium glutamicum b

—

Q79VJ3.1

Cryptococcus neoformans var.

AF006062.1

—

—

P18314.1,

Campylobacter sputorum b
Coccidiodes posadasii f
Coccidioides immitis f

grubii f
Enterobacter aerogenes b

P18316.1
Escherichia coli (O157:H7) b

—

Q8XAG0.1

Fission yeast (Saccharomyces

—

O00084.1

pombe) f
Note: Urease nucleotide and protein sequences used for in silico identification of an elasmobranch-synthesized urease.
Subscripts indicate taxonomic kingdom: bacteria (b), fungi (f), and plant(p).
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Table A1 (continued).
L25079.1

—

AB018202.1

P14916.2

Jack bean (Canavalia ensiformis) p

M65260.1

P07374.3

Klebsiella pneumoniae b

L07039.1

—

NM_105422.4

Q9SR52.1

Mycobacterium tuberculosis b

—

P9WFF1.1

Neosartorya fumigate f

—

Q6A3P9.2

KF312589.1

—

—

Q9L664.1

—

P17086.2

Pseudogymnoascus pannorum f

KP195073.1

—

Pseusogymnoascus destructans f

KP195072.1

—

CAOJ01012310.1

—

—

E0ZS48.1

AJ308543.1,

—

Heliobacter heilmannii b
Heliobacter pylori b

Mouse-ear cress (Arabidopsis
thaliana) p

Pleurotus ostreatus f
Prochlorococcus marinus sub.
Pastoris b
Proteus mirabilis b

Rhizoctonia solani f
Rice (Oryza sativa sub. Indica) p
Solanum tuberosum p

AJ308544.1
Sporosarcina pasteurii b

—

P41020.1

Staphylococcus saprophyticus b

—

Q4A0J5.3

Note: Urease nucleotide and protein sequences used for in silico identification of an elasmobranch-synthesized urease.
Subscripts indicate taxonomic kingdom: bacteria (b), fungi (f), and plant(p).
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Table A1 (continued).
—

P50047.3

JQ612071.1

—

JQ612049.1

—

Ureaplasma urealyticum b

L40490.1

—

Vibrio parahaemolyticus b

D86348.1

—

Yersinia enterocolitica b

L24101.1

P31494.3

Streptococcus salivarius b
Uncultured rumen bacterium clone
SU134 b
Uncultured rumen bacterium clone
SU75 b

Note: Urease nucleotide and protein sequences used for in silico identification of an elasmobranch-synthesized urease.
Subscripts indicate taxonomic kingdom: bacteria (b), fungi (f), and plant(p).

Table A2.
FMO sequences queried
Organism

Accession number
Nucleotide/mRNA

Protein

XM_018253772.1

—

—

AAH91044.1

Oncorhynchus mykiss

EU519462.1

ACC95536.1

Gallu gallus

AH012591.2p

NP_989910.1

Sus scrofa

DQ532373.1 p

—

XM_007889361.1

XP_007887552.1

Xenopus laevis*
Xenopus tropicalis

Callorhinchus milii*

Note: FMO nucleotide and protein sequences used for in silico identification of an elasmobranch-synthesized FMO. Taxa
marked with an asterisk (*) are NCBI predicted FMO sequences. Accession numbers marked ‘p’ indicates partial FMO
sequences.
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Table A2 (continued).
Latimeria chalumnae*

—

XP_014352628.1

Danio rerio*

—

XP_001332968.4

Cynoglossus semilaevis*

—

XP_008331640.1

Homo sapiens

AH006707.2

—

Mus musculus

—

BAA03745.1

Pan troglodytes

AH012919.2

—

Bos Taurus

AF488421.1p

AAI02684.1

Note: FMO nucleotide and protein sequences used for in silico identification of an elasmobranch-synthesized FMO. Taxa
marked with an asterisk (*) are NCBI predicted FMO sequences. Accession numbers marked ‘p’ indicates partial FMO
sequences.

Table A3.
Antibiotic efficacy qRT-PCR primer sequences
Gene

Primer

Primer sequence

16S rRNA V2 region

Forward

5’-AGYGGCGIACGGGTGAGTAA-3’

16S rRNA V2 region

Reverse

5’-CYIACTGCTGCCTCCCGTAG-3’

Fish actin

Forward

5’-TCGTCATGGACTCTGGTGATGG-3’

Fish actin

Reverse

5’-CTCCTGCTCAAAGTCCAGTGC-3’

Note: qRT-PCR primers for 16S quantification of bacteria in D. sabina gut scrapes from control and antibiotic-dosed
animals (Reikvam et al. 2011).
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Table A4.
Liver CPS III qRT-PCR primer sequences
Gene

Primer

Primer sequence

CPS III

Forward

5’-ATATCCTGTGGCCTTTGACG-3’

CPS III

Reverse

5’-GAAACTGCGATCAAGGTGGT-3'

18S

Forward

18S

Reverse

5’-GTTAATTCCGATAACGAACGAGACTC3’
5’-ACAGACCTGTTATTGCTCAATCTCGTG3’

Note: qRT-PCR primers for quantification of CPS III expression in D. sabina liver tissue from control and antibiotic-dosed
animals.
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